Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Oncobiologics, Inc. (OTLK) had Normalized Income after Taxes of $17.38M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$17.38M |
|
-- |
|
-- |
|
$21.61M |
|
$-21.61M |
|
$38.98M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
$17.38M |
|
|
Normalized Income after Taxes |
$17.38M |
$-21.61M |
|
$-21.58M |
|
24.23M |
|
24.23M |
|
$0.72 |
|
$0.72 |
|
| Balance Sheet Financials | |
$15.67M |
|
-- |
|
$1.34M |
|
$17.01M |
|
$48.24M |
|
-- |
|
$19.06M |
|
$67.30M |
|
$-50.29M |
|
$-50.29M |
|
$-50.29M |
|
24.91M |
|
| Cash Flow Statement Financials | |
$-10.97M |
|
-- |
|
$1.74M |
|
$14.93M |
|
$5.70M |
|
$-9.22M |
|
$3.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.32 |
|
-- |
|
-- |
|
-- |
|
-0.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.55% |
|
-34.55% |
|
102.18% |
|
-34.55% |
|
$-2.02 |
|
$-0.45 |
|
$-0.45 |
|